This topic contains a solution. Click here to go to the answer

Author Question: Monochromatic light (l = 500 nm) is incident on a soap bubble (n = 1.40). How thick is the bubble ... (Read 336 times)

rosent76

  • Hero Member
  • *****
  • Posts: 516
Monochromatic light (l = 500 nm) is incident on a soap bubble (n = 1.40). How thick is the bubble (in nm) if destructive interference occurs in the reflected light?
 a. 102
  b. 179
  c. 54
  d. 1
  e. 89

Question 2

Monochromatic light (l = 500 nm) is incident on a soap bubble (n = 1.4) that is 500-nm thick. Calculate the change of phase of the light that penetrates the front surface, reflects from the second surface, and emerges through the first surface as an angle between 0 and 360?
 a. 280
  b. 160
  c. 220
  d. 100
  e. 290



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

pikon

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

B

Answer to Question 2

E




rosent76

  • Member
  • Posts: 516
Reply 2 on: Jul 28, 2018
Excellent


kthug

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

The average older adult in the United States takes five prescription drugs per day. Half of these drugs contain a sedative. Alcohol should therefore be avoided by most senior citizens because of the dangerous interactions between alcohol and sedatives.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Addicts to opiates often avoid treatment because they are afraid of withdrawal. Though unpleasant, with proper management, withdrawal is rarely fatal and passes relatively quickly.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library